生命科学资讯
生物技术与制药领域的最新动态
Roche GLP-1 produces “robust” weight loss in late-stage obesity trial - European Pharmaceutical Review
Roche drops $100M Kiniksa fibrosis drug from phase 2 pipeline as part of quarterly clearout - Fierce Biotech
罗氏公布GLP-1/GIP双重受体激动剂二期研究积极结果 | 医药行业高管
Roche Reports Positive Phase II Study Results for Dual GLP-1/GIP Receptor Agonist | PharmExec - Pharmaceutical Executive
罗氏肥胖症突破后如何扩大生产规模 - 制造数字杂志
How Roche is Scaling Production After Obesity Breakthrough - Manufacturing Digital Magazine
罗氏旗下Carmot的GLP1/GIP药物实现22.5%减重效果，准备启动三期临床试验——Fierce Biotech
Roche sees GLP1/GIP drug from Carmot produce 22.5% weight loss, readies phase 3 trial - Fierce Biotech
罗氏宣布实验性肥胖药物二期临床试验结果积极 - wkzo.com
Roche announces positive phase II results for experimental obesity drug - wkzo.com
罗氏Gazyva获加拿大卫生部批准用于狼疮肾炎治疗 - marketscreener.com
Roche's Gazyva gets Health Canada approval for lupus nephritis - marketscreener.com
Anthropic、罗氏与英伟达：本周医疗数字化热点聚焦
Anthropic, Roche & NVIDIA: This Week's Top Stories - Healthcare Digital
罗氏：让预防性医疗保健惠及所有人 - 医疗保健数字化
Roche: Making Preventative Healthcare Accessible to All - Healthcare Digital
前罗氏肿瘤部门负责人转投Tubulis——职业阶梯的升降记
Former Roche oncology head turns to Tubulis—Chutes & Ladders - fiercebiotech.com
罗氏重返中国生物技术公司美迪凯，达成另一项ADC合作协议
Roche returns to Chinese biotech MediLink for another ADC pact - Endpoints News
罗氏重返美迪联，以5.7亿美元近期付款获取ADC技术——Fierce Biotech报道
Roche returns to MediLink with $570M near-term payments for ADC - Fierce Biotech
罗氏斥资1亿美元强化GLP-1药物布局，与Structure达成许可协议
In Structure licensing deal, Roche commits $100M to shore up GLP-1 position - Fierce Biotech
罗氏通过结构专利协议解决肥胖症药物法律问题 - BioSpace
Roche Clears Obesity Pill Legal Concerns With Structure Patent Agreement - BioSpace
基于人工智能的数字病理学市场情报报告，2025-2035年，重点介绍Aiforia Technologies、Ibex Medical Analytics、Indica Labs、PathAI、罗氏、Visiopharm等多家主要参与者 - ResearchAndMarkets.com - AI期刊
AI-based Digital Pathology Market Intelligence Report, 2025-2035, Featuring Aiforia Technologies, Ibex Medical Analytics, Indica Labs, PathAI, Roche, Visiopharm and Many Other Key Players - ResearchAndMarkets.com - The AI Journal
艾默生与罗氏合作开发制药数字化模态库——自动化世界
Emerson and Roche Collaborate on Digital Modality Library for Pharmaceutical Development - Automation World
罗氏Lunsumio VELO获美国FDA批准用于滤泡性淋巴瘤皮下注射治疗——医学对话
Roche Lunsumio VELO bags USFDA approval for subcutaneous use in follicular lymphoma - Medical Dialogues
今日ROG.SW新闻：特朗普药物计划提振罗氏股价于12月22日 - Meyka
ROG.SW News Today: Trump Drug Plan Boosts Roche Stock on December 22 - Meyka
罗氏与诺华接近与特朗普达成价格协议 - medwatch.com
Roche and Novartis close to price agreement with Trump - medwatch.com